Cadrenal Therapeutics, Inc. Common Stock (CVKD) vs Evogene Ltd. (EVGN)

A side-by-side comparison of Cadrenal Therapeutics, Inc. Common Stock and Evogene Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CVKD

Cadrenal Therapeutics, Inc. Common Stock

$3M

$0.93HealthcareDelayed quote: Oct 6, 2026, 11:01 AM EDT

EVGN

Evogene Ltd.

$3M

$0.40HealthcareDelayed quote: Oct 6, 2026, 11:02 AM EDT

Total return — CVKD vs EVGN

growth of $100 · dividends reinvested · last 4y

CVKD -98.5% (-64.8%/yr)EVGN -94.7% (-52.1%/yr)EVGN compounded faster over this window

CVKD EVGN

CVKD vs EVGN: by the numbers

•EVGN is the larger company ($3M vs $3M market cap).
•Both run net losses; CVKD's is the smaller (0.00% vs -694.19% net margin).

Metrics side by side

Valuation

Metric	CVKD	EVGN
P/S ratio	N/A	2.60
P/B ratio	0.81	N/A

Profitability

Metric	CVKD	EVGN
Gross margin	0.00%	-6.25%
Operating margin	0.00%	-364.24%
Net margin	0.00%	-694.19%
ROE	-282.13%	N/A
ROIC	-284.81%	-130.12%

Growth (annualized)

Metric	CVKD	EVGN
Revenue CAGR (5Y)	N/A	2.86%
Total return CAGR (5Y)	N/A	-56.46%

Go deeper

Full CVKD analysis Full EVGN analysis Interactive comparison tool

Dig into the metrics

Cadrenal Therapeutics, Inc. Common Stock ROE Evogene ROE Cadrenal Therapeutics, Inc. Common Stock operating margin Evogene operating margin Cadrenal Therapeutics, Inc. Common Stock revenue growth Evogene revenue growth Cadrenal Therapeutics, Inc. Common Stock free cash flow Evogene free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.